Stockreport

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results fo [Read more]